The GSK-3 family as therapeutic target for myocardial diseases.
Ontology highlight
ABSTRACT: Glycogen synthase kinase-3 (GSK-3) is one of the few signaling molecules that regulate a truly astonishing number of critical intracellular signaling pathways. It has been implicated in several diseases including heart failure, bipolar disorder, diabetes mellitus, Alzheimer disease, aging, inflammation, and cancer. Furthermore, a recent clinical trial has validated the feasibility of targeting GSK-3 with small molecule inhibitors for human diseases. In the current review, we will focus on its expanding role in the heart, concentrating primarily on recent studies that have used cardiomyocyte- and fibroblast-specific conditional gene deletion in mouse models. We will highlight the role of the GSK-3 isoforms in various pathological conditions including myocardial aging, ischemic injury, myoca
SUBMITTER: Lal H
PROVIDER: S-EPMC4283216 | biostudies-literature | 2015 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA